VectorY Therapeutics doses first participant in phase 1/2 PIONEER-ALS trial to evaluate VTx-002 in people with amyotrophic lateral sclerosis: Amsterdam Wednesday, February 11, 202 ...
Immune cells in the brain that go rogue contribute to the death of neurons, so getting rid of them may slow the progression of neurodegenerative conditions like amyotrophic lateral sclerosis ...
ALS is characterized by the death of motor neurons, leading to progressive muscle weakness and loss of voluntary movement. Sporadic ALS accounts for approximately 90-95% of cases, while familial ALS ...
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...
This study showed that certain harmful gut microbes generate a type of sugar known as glycogen, which can lead to immune responses that interfere with the brain, said senior study author Aaron ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics ...
Ross "The Boss" Friedman of The Dictators and Manowar has been diagnosed with amyotrophic lateral sclerosis (ALS). "It's ...
A neurologist and a multidisciplinary team are required for the management of ALS. Whenever possible, primary care clinicians should refer the patient to a specialized ALS clinic. Treatments to manage ...
The recent diagnosis of Amyotrophic Lateral Sclerosis (ALS) profoundly affected the life of Mexican producer Pedro Torres Castilla, who passed away on January 30, 2026. This tragic event, alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results